In suspected acute coronary syndrome, what is the initial antiplatelet therapy you should administer?

Prepare for the ACLS ProMed Test with our study tools. Access flashcards and multiple choice questions, each with hints and explanations. Equip yourself for success!

Multiple Choice

In suspected acute coronary syndrome, what is the initial antiplatelet therapy you should administer?

Explanation:
Rapid platelet inhibition is the goal in suspected ACS. Chewing aspirin provides fast absorption and a quick antiplatelet effect, which helps blunt ongoing thrombosis at the culprit lesion. The recommended loading dose is 162–325 mg, and chewing it accelerates onset compared with swallowing. Intravenous heparin is an anticoagulant, not an antiplatelet therapy, so it does not fulfill the need for immediate platelet inhibition. Clopidogrel can be added as part of dual antiplatelet therapy, but the initial step is a chewable aspirin loading dose to achieve rapid platelet suppression.

Rapid platelet inhibition is the goal in suspected ACS. Chewing aspirin provides fast absorption and a quick antiplatelet effect, which helps blunt ongoing thrombosis at the culprit lesion. The recommended loading dose is 162–325 mg, and chewing it accelerates onset compared with swallowing. Intravenous heparin is an anticoagulant, not an antiplatelet therapy, so it does not fulfill the need for immediate platelet inhibition. Clopidogrel can be added as part of dual antiplatelet therapy, but the initial step is a chewable aspirin loading dose to achieve rapid platelet suppression.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy